Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Amplia Therapeutics ( (AU:ATX) ) has issued an announcement.
Amplia Therapeutics Limited has announced a change in the interests of a substantial holder, Acorn Capital Limited, which acts as an investment manager for various superannuation funds, institutional investor portfolios, and unit trusts. This change affects the voting power and number of securities held by Acorn Capital in Amplia Therapeutics. The announcement reflects a decrease in voting power from 8.91% to 7.70%, indicating a shift in Acorn Capital’s stake in the company, which may influence the company’s shareholder dynamics and decision-making processes.
More about Amplia Therapeutics
Average Trading Volume: 2,267,737
Technical Sentiment Signal: Sell
Current Market Cap: A$25.6M
See more insights into ATX stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “…Supporting the Responsible Growth of our Industry…” Boeing Stock (NYSE:BA) Notches Up With Carbon Purchase
- “Secure Foundations for the Era of Frontier AI”: Microsoft Stock (NASDAQ:MSFT) Gains With New AI Plans
- Elon Musk Made $158 Billion in 2025, But Received None of It. Tesla Stock (NASDAQ:TSLA) Surges